Human MRC2 activation kit by CRISPRa

CAT#: GA106688

MRC2 CRISPRa kit - CRISPR gene activation of human mannose receptor C type 2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
MRC2 mouse monoclonal antibody,clone OTI9G4
    • 100 ul

CNY 1,999.00
CNY 2,700.00


MRC2 (Myc-DDK-tagged)-Human mannose receptor, C type 2 (MRC2)
    • 10 ug

CNY 15,176.00


MRC2 mouse monoclonal antibody,clone OTI9G4
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol MRC2
Locus ID 9902
Kit Components

GA106688G1, MRC2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA106688G2, MRC2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA106688G3, MRC2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_006039
Synonyms CD280; CLEC13E; ENDO180; UPARAP
Summary This gene encodes a member of the mannose receptor family of proteins that contain a fibronectin type II domain and multiple C-type lectin-like domains. The encoded protein plays a role in extracellular matrix remodeling by mediating the internalization and lysosomal degradation of collagen ligands. Expression of this gene may play a role in the tumorigenesis and metastasis of several malignancies including breast cancer, gliomas and metastatic bone disease. [provided by RefSeq, Feb 2012]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...